File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level

TitleSurvival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level
Authors
Issue Date2017
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1743-7563
Citation
Asia-Pacific Journal of Clinical Oncology, 2017, v. 13 n. 2, p. e65-e71 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/207765
ISSN
2017 Impact Factor: 1.494
2015 SCImago Journal Rankings: 0.554
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorTeoh, JYC-
dc.contributor.authorTsu, HLJ-
dc.contributor.authorYuen, SKK-
dc.contributor.authorChan, SYS-
dc.contributor.authorChiu, PKF-
dc.contributor.authorWong, JKW-
dc.contributor.authorHo, KL-
dc.contributor.authorHou, SSM-
dc.contributor.authorNg, CF-
dc.contributor.authorYiu, MK-
dc.date.accessioned2015-01-19T10:18:16Z-
dc.date.available2015-01-19T10:18:16Z-
dc.date.issued2017-
dc.identifier.citationAsia-Pacific Journal of Clinical Oncology, 2017, v. 13 n. 2, p. e65-e71-
dc.identifier.issn1743-7555-
dc.identifier.urihttp://hdl.handle.net/10722/207765-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1743-7563-
dc.relation.ispartofAsia-Pacific Journal of Clinical Oncology-
dc.rightsThis is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.titleSurvival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level-
dc.typeArticle-
dc.identifier.emailTsu, HLJ: jamestsu@hku.hk-
dc.identifier.emailHo, KL: hkl218@hkucc.hku.hk-
dc.identifier.emailYiu, MK: pmkyiu@hku.hk-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/ajco.12313-
dc.identifier.pmid25471685-
dc.identifier.hkuros242208-
dc.identifier.volume13-
dc.identifier.issue2-
dc.identifier.spagee65-
dc.identifier.epagee71-
dc.identifier.isiWOS:000397390400008-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats